Compound 60 has an extremely higher affinity to MDM2 (Ki < 1 nM), strong mobile exercise, and a very good oral pharmacokinetic profile. Compound 60 is able to attaining entire and lengthy-lasting tumor regression in vivo and is also at this time in phase I clinical trials for cancer cure. https://richardc085tyd9.theblogfairy.com/profile